Advertisement

Topics

Vensun Pharmaceuticals, Inc. Completes Series C Financing

11:00 EST 1 Dec 2016 | Biotech 365

YARDLEY, Pa.–(BUSINESS WIRE)–Vensun Pharmaceuticals, Inc. (“Vensun” or “the Company”), a privately held generic pharmaceuticals company, today announced the completion of $22.5 million Series C preferred financing with a consortium of investors led by Perceptive Advisors, LLC. Deerfield Management Company, L.P. … Continue reading

Cet article Vensun Pharmaceuticals, Inc. Completes Series C Financing est apparu en premier sur Biotech 365.

Original Article: Vensun Pharmaceuticals, Inc. Completes Series C Financing

NEXT ARTICLE

More From BioPortfolio on "Vensun Pharmaceuticals, Inc. Completes Series C Financing"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...